MGLL and cancer: Furthermore, as Deng et al. suggested in an authentic review, monoacylglycerol lipase (MAGL) inhibitors can not only act as anti-cancer agents but also relieve cancer-associated symptoms such as pain, nausea, and vomiting [207].